ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994

Some Of Community Contractors Won’t Survive, Some “Superb,” Some May Get More Time, Money

June 11, 1976

NCCS Selects New President

October 9, 2009

In Brief: Auto Workers Not At Increased risk Of Bladder Cancer, But Truck Drivers Are, New Study Shows

March 11, 1983

RFPS, RFAs Available

September 23, 1994

Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI

April 22, 1994